Thomas Gad Net Worth & Insider Trades

Thomas Gad - See remarks, Y-Mabs Therapeutics, Inc

As of May 19, 2022

What is Thomas Gad's Net Worth?

The current estimated net worth of Y-Mabs Therapeutics, Inc's See remarks, Thomas Gad, is estimated to be about $54.23M . Thomas Gad owns about 615,032 units of Y-Mabs Therapeutics, Inc common stock. In the last 4 years at Y-Mabs Therapeutics, Inc, Thomas Gad has sold an estimated value of $42.82M worth.

What is Thomas Gad's Past Insider Trading?

Thomas Gad's largest purchase order was 100,000 units , worth over $200K on December 14, 2020. Thomas Gad's largest sale order was 250,000 units , worth over $6.47M on April 11, 2019. In total, Thomas Gad has made about 87 transactions over 4 years of their time at Y-Mabs Therapeutics, Inc. Thomas Gad usually trades in December, with the busiest year in 2020. The most recent transaction was a sale order of 281,170 units , worth over $2.02M on February 9, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Thomas Gad's' Mailing Address?

  • Mailing address is C/o Y-Mabs Therapeutics, Inc. 230 Park Avenue, 33rd Floor New York NY 10169 NY

What are Y-Mabs Therapeutics, Inc's Past Insider Trades?

Y-Mabs Therapeutics, Inc's most recent insider trade came on November 16, 2022 by Vignesh Rajah who bought 1,195 units worth $5.88K . In the last 4 years, insiders at Y-Mabs Therapeutics, Inc have sold an estimated value of $93.08M and bought an estimated value of $19.21M worth of shares. Insider trading is most common in December, with the busiest year in 2021. The most active traders at the company are Thomas Gad, See remarks,  Bo Kruse, EVP,  and Johan Wedell-Wedellsborg, Director .

Y-mAbs Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1